Skip to content

Trueblue TBI Proceeds from exercises of stock options and other stock issuances

Proceeds from exercises of stock options and other stock issuances at other companies

Korn Ferry logo
Korn FerryKFY

Other financials

Income statement

See full
Revenue$398.6M+7.6%
Gross profit$79.0M-8.5%
Operating income-$17.8M-26.4%
Net income-$19.8M-38.0%
EPS (diluted)-$0.66-37.5%

Balance sheet

See full
Cash & equivalents$24.1M+4.7%
Total debt$130.4M+13.2%
Total equity$256.1M-15.3%
Total assets$620.7M-10.4%

Cash flow

See full
Operating cash flow-$9.8M+55.8%
CapEx$2.8M-39.6%
Free cash flow-$12.6M+52.9%

Valuation

See full
Market cap$205.23M+4.8%
Enterprise value$311.53M+9.7%
P/S0.1×0.0×

Profitability

See full
Gross margin21.9%-3.7pp
Operating margin-3.1%-1.0pp
Net margin-3.2%-1.3pp
FCF margin-3.6%+0.8pp

Returns & leverage

See full
Return on equity-19.1%-6.2pp
Debt / equity0.5×+0.1×
Current ratio2.1×+0.3×

Where this comes from

Reported directly by Trueblue in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions.

The official record: Trueblue’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Trueblue's proceeds from exercises of stock options and other stock issuances.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Trueblue's proceeds from exercises of stock options and other stock issuances?
Trueblue (TBI) reported proceeds from exercises of stock options and other stock issuances of $162K in Q1 2026.
How has Trueblue's proceeds from exercises of stock options and other stock issuances changed year-over-year?
Trueblue's proceeds from exercises of stock options and other stock issuances increased by 131.4% year-over-year, from $70K to $162K.
What is the long-term trend for Trueblue's proceeds from exercises of stock options and other stock issuances?
Over 4 years (2021 to 2025), Trueblue's proceeds from exercises of stock options and other stock issuances has grown at a -20.5% compound annual growth rate (CAGR), from $1.14M to $454K.